CING Insider Trading

Cingulate Inc. · full profile →Last filing Mar 9, 2026
Net Buying · 180d
Open-Market Buys (180d)
$657K
5 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$657K
open market, 180d
Reporting Insiders
5
5 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Recent Form 4 Transactions

94 shown
DateInsiderRoleActionSharesPriceValue
Mar 9, 2026Hargroves Thomas JeffreyDirectorGrant(A)15K$0
Mar 9, 2026Brams MatthewEVP and Chief Medical OfficerTax withholding(F)1K$0
Mar 9, 2026Brams MatthewEVP and Chief Medical OfficerGrant(A)5K$0
Mar 9, 2026Callahan Jennifer L.EVP and CFOTax withholding(F)6K$0
Mar 9, 2026Callahan Jennifer L.EVP and CFOGrant(A)15K$0
Mar 9, 2026Patel Nilay DahyabhaiEVP, CLO and CCOTax withholding(F)2K$0
Mar 9, 2026Patel Nilay DahyabhaiEVP, CLO and CCOGrant(A)5K$0
Mar 9, 2026Schaffer Shane J.Chief Executive Officer, DirectorTax withholding(F)3K$0
Mar 9, 2026Schaffer Shane J.Chief Executive Officer, DirectorGrant(A)7K$0
Mar 9, 2026Silva Raul R.EVP and CSOGrant(A)5K$0
Mar 9, 2026Silva Raul R.EVP and CSOTax withholding(F)2K$0
Feb 13, 2026Hargroves Thomas JeffreyDirectorBuy(P)97K$5.04$490K
Feb 13, 2026Hargroves Thomas JeffreyDirectorBuy(P)78K$0.10$8K
Feb 6, 2026Brams MatthewEVP and Chief Medical OfficerBuy(P)2K$5.04$10K
Feb 6, 2026Brams MatthewEVP and Chief Medical OfficerBuy(P)2K$0.10$156
Feb 6, 2026Schaffer Shane J.Chief Executive Officer, DirectorBuy(P)7K$5.04$34K
Feb 6, 2026Schaffer Shane J.Chief Executive Officer, DirectorBuy(P)5K$0.10$545
Feb 6, 2026Callahan Jennifer L.SVP and CFOBuy(P)5K$5.04$25K
Feb 6, 2026Callahan Jennifer L.SVP and CFOBuy(P)4K$0.10$389
Feb 6, 2026Werth Peter J.DirectorBuy(P)19K$5.04$98K
Feb 6, 2026Werth Peter J.DirectorBuy(P)16K$0.10$2K
Dec 31, 2025Silva Raul R.EVP and CSOGrant(A)7K$0
Nov 3, 2025Downey Bryan WadeChief Commercial OfficerGrant(A)30K$0
Sep 30, 2025Silva Raul R.EVP and CSOGrant(A)7K$0
Jul 8, 2025Patel Nilay DahyabhaiCLO and CCOGrant(A)30K$0
Jul 7, 2025Brams MatthewEVP and Chief Medical OfficerGrant(A)53K$0
Jul 7, 2025Callahan Jennifer L.SVP and CFOGrant(A)65K$0
Jul 7, 2025Myers LaurieEVP and COOGrant(A)31K$0
Jul 7, 2025Schaffer Shane J.Chief Executive Officer, DirectorGrant(A)200K$0
Jul 7, 2025Silva Raul R.EVP and CSOGrant(A)52K$0
Jun 30, 2025Silva Raul R.EVP and CSOGrant(A)1K$0
Jun 20, 2025Ervin Jeffrey SDirectorGrant(A)15K$0
Jun 20, 2025Lawrence Bryan JayDirectorGrant(A)15K$0
Jun 20, 2025Roberts John ADirectorGrant(A)15K$0
Jun 20, 2025Werth Peter J.DirectorGrant(A)15K$0
Mar 31, 2025Silva Raul R.EVP and CSOGrant(A)1K$0
Feb 18, 2025Silva Raul R.EVP and CSOGrant(A)18K$0
Feb 18, 2025Brams MatthewEVP and Chief Medical OfficerGrant(A)18K$0
Feb 18, 2025Myers LaurieEVP and COOGrant(A)18K$0
Feb 18, 2025Schaffer Shane J.Chief Executive Officer, DirectorGrant(A)70K$0
Feb 18, 2025Callahan Jennifer L.SVP and CFOGrant(A)21K$0
Jan 17, 2025Brams MatthewEVP and Chief Medical OfficerGrant(A)3K$0
Jan 17, 2025Schaffer Shane J.Chief Executive Officer, DirectorGrant(A)28K$0
Jan 17, 2025Myers LaurieEVP and COOGrant(A)9K$0
Jan 17, 2025Silva Raul R.EVP and CSOGrant(A)3K$0
Jan 17, 2025Callahan Jennifer L.SVP and CFOGrant(A)12K$0
Dec 31, 2024Brams MatthewEVP and Chief Medical OfficerGrant(A)1K$0
Dec 31, 2024Silva Raul R.EVP and CSOGrant(A)1K$0
Sep 30, 2024Brams MatthewEVP and Chief Medical OfficerGrant(A)1K$0
Sep 30, 2024Silva Raul R.EVP and CSOGrant(A)1K$0
Aug 15, 2024Myers LaurieEVP and COOSell(S)202$4.17$842
Jun 28, 2024Brams MatthewEVP and Chief Medical OfficerGrant(A)1K$0
Jun 28, 2024Silva Raul R.EVP and CSOGrant(A)1K$0
Jun 12, 2024Ervin Jeffrey SDirectorGrant(A)10K$0
Jun 12, 2024Lawrence Bryan JayDirectorGrant(A)10K$0
Jun 12, 2024Roberts John ADirectorGrant(A)10K$0
Jun 12, 2024Werth Peter J.Director, 10% OwnerGrant(A)10K$0
Jun 11, 2024Ervin Jeffrey SDirectorGrant(A)14K
Jun 11, 2024Ervin Jeffrey SDirectorGrant(A)5K$0
Jun 11, 2024Brams MatthewEVP and Chief Medical OfficerGrant(A)63K$0
Jun 11, 2024Lawrence Bryan JayDirectorGrant(A)5K$0
Jun 11, 2024Lawrence Bryan JayDirectorGrant(A)14K
Jun 11, 2024Callahan Jennifer L.SVP and CFOGrant(A)95K$0
Jun 11, 2024Roberts John ADirectorGrant(A)5K$0
Jun 11, 2024Roberts John ADirectorGrant(A)15K
Jun 11, 2024Myers LaurieEVP and COOGrant(A)99K$0
Jun 11, 2024Schaffer Shane J.Chief Executive Officer, DirectorGrant(A)218K$0
Jun 11, 2024Silva Raul R.EVP and CSOGrant(A)63K$0
Jun 11, 2024Werth Peter J.Director, 10% OwnerGrant(A)7K
Apr 11, 2024Werth Peter J.Director, 10% OwnerOption exercise(M)342K$0
Apr 11, 2024Werth Peter J.Director, 10% OwnerOption exercise(M)694K$0
Apr 11, 2024Werth Peter J.Director, 10% OwnerOption exercise(M)342K$0
Apr 11, 2024Werth Peter J.Director, 10% OwnerOption exercise(M)694K$0
Mar 29, 2024Silva Raul R.EVP and CSOGrant(A)1K$0
Mar 29, 2024Brams MatthewEVP and Chief Medical OfficerGrant(A)1K$0
Mar 25, 2024Werth Peter J.Director, 10% OwnerOther(J)7K
Mar 4, 2024Lawrence Bryan JayDirectorGrant(A)5K$0
Mar 4, 2024Callahan Jennifer L.SVP and CFOGrant(A)25K$0
Mar 4, 2024Ervin Jeffrey SDirectorGrant(A)5K$0
Mar 4, 2024Myers LaurieEVP and COOGrant(A)26K$0
Mar 4, 2024Brams MatthewEVP and Chief Medical OfficerGrant(A)17K$0
Mar 4, 2024Werth Peter J.DirectorGrant(A)2K
Mar 4, 2024Roberts John ADirectorGrant(A)5K$0
Mar 4, 2024Schaffer Shane J.Chief Executive Officer, DirectorGrant(A)57K$0
Mar 4, 2024Silva Raul R.EVP and CSOGrant(A)17K$0
Jan 25, 2024Werth Peter J.Director, 10% OwnerOther(J)687K
Dec 29, 2023Silva Raul R.EVP and CSOGrant(A)1K$0
Sep 29, 2023Silva Raul R.EVP and CSOGrant(A)10K$0
Sep 15, 2023Callahan Jennifer L.Corporate ControllerBuy(P)5K$0.67$3K
Sep 8, 2023Werth Family Investment Associates LLC10% OwnerOther(J)6.8M
Aug 11, 2023Werth Peter J.DirectorBuy(P)1.8M$0.55$1.0M
Jun 30, 2023Silva Raul R.EVP and CSOGrant(A)10K$0
Mar 15, 2022Callahan Jennifer L.SVP and CFOBuy(P)55$27.10$1K
Mar 15, 2022Callahan Jennifer L.SVP and CFOBuy(P)2K$0.30$450

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).